CliffBio
small molecule

DESMODA

DESMOPRESSIN ACETATE

Loss of exclusivityApril 2044latest FDA-listed patent expiry
CompanyEton Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameDESMODA
Active ingredientDESMOPRESSIN ACETATE
Strength0.05MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2026
Marketing statusRX

Listed patents

PatentExpiresType
12343372April 2044product
12214010April 2044product

More from Eton Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

DESMODA patent cliff — loss of exclusivity April 2044 | CliffBio